Your browser doesn't support javascript.
loading
CD19 epitope masking by tafasitamab leads to delays in subsequent use of CD19 CAR T-cell therapy in two patients with aggressive mature B-cell lymphomas.
Fitzgerald, Kelly N; Quesada, Andres E; von Keudell, Gottfried; Raj, Sandeep; Lewis, Natasha E; Dogan, Ahmet; Salles, Gilles; Palomba, M Lia.
Affiliation
  • Fitzgerald KN; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Quesada AE; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • von Keudell G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Raj S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lewis NE; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Dogan A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Salles G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Palomba ML; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Leuk Lymphoma ; 63(3): 751-754, 2022 03.
Article in En | MEDLINE | ID: mdl-34949132
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Lymphoma, B-Cell Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Lymphoma, B-Cell Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: